Has Sarim Ahmed, MD received payments from drug or device companies?

Yes. Drug and device makers reported $25,572 in general payments to Sarim Ahmed, MD across 143 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sarim Ahmed, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sarim Ahmed, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sarim Ahmed, MD

Adult Reconstructive Orthopaedic Surgery · Scottsdale, AZNPI 1649433137

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Nalu Medical, Inc. accounts for 65.5% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $15,784, more than ten times the $1,122 reported in 2019.

$25,572in general payments, 2019–2025

Across 143 payments — averaging $178.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nalu Medical, Inc.$17K
Terumo BCT, Inc.$3K
Smith+Nephew$2K
Stryker$1K
Johnson & Johnson$808
Abbott$451
plus $1K from 17 others

What the payments were for

Consulting fees$14,40056%
Speaking & faculty fees$4,65018%
Travel & lodging$9044%
Food & beverage$5,51822%
Education$1000%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nalu Medical, Inc.	51	$16,757
Terumo BCT, Inc.	9	$2,879
Smith+Nephew	10	$2,352
Stryker	22	$1,144
Johnson & Johnson(2 entities)	15	$808
Abbott	6	$451
Pacira Therapeutics, Inc.	8	$162
Integra Lifesciences Corporation	2	$156
Medartis Inc.	1	$122
Medtronic	1	$117
Zimmer Biomet	2	$110
Dynasplint Systems Inc.	2	$95
Next Science LLC	1	$95
Onkos Surgical, Inc.	2	$84
Bioventus LLC	2	$41
Fidia Pharma USA Inc.	2	$38
Medacta USA, Inc.	1	$37
Goode Surgical Inc	1	$25
AbbVie	1	$25
Endo Pharmaceuticals Inc.	1	$22
Molnlycke Health Care US, LLC	1	$22
Ferring Pharmaceuticals Inc.	1	$15
Theragen, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Nalu Neurostimulation System$15,890
HARVEST SmartPrep$2,625
BIORAPTOR Shoulder$2,025
MAKO$613
PROCLAIM$269
NA$214
INTEGRA MESHED BILAYER WOUND MATRIX$132
INTEGRA WOUND MATRIX (IWM)$132
PRIMATRIX$132
INTEGRA DERMAL REGENERATION TEMPLATE$132
INTEGRA FLOWABLE WOUND MATRIX$132
VA-LCP PLATES & SCREWS$131
EXTERNAL FIXATION$123
APTUS$122
ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY$117
TFN-Advance$110
Regeneten$102

How this compares

$25,572 in reported general payments places this provider in the 70th percentile of 43 adult reconstructive orthopaedic surgery providers in Arizona.

See all adult reconstructive orthopaedic surgery providers in Arizona →

Medicare billing

Part B allowed, 2024

$223,984

Medicare patients

279

Services billed

2,989

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cyclobenzaprine Hcl	25	$465
Gabapentin	11	$128
Meloxicam	23	$51

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Scottsdale

Daniel GalatScottsdale$12K
Theodore FirestoneScottsdale$1K
Stuart KozinnScottsdale$51
Michael MillerTucson$2.3M
Russell CohenTucson$970K
Steven MyerthallGilbert$691K
Salvatore LacognataGilbert$445K
Lige KaplanPhoenix$327K
Abigail HamiltonTucson$150K
Paul SousaBuckeye$70K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →